Abstract |
Many breast cancer cells acquire multidrug resistance (MDR) mediated by ABC transporters such as breast cancer resistance protein (BCRP/ABCG2). Here we show that incubation of human breast cancer MDA-MB-231 cells with farnesoid X receptor antagonist guggulsterone (gug) and retinoid X receptor agonist bexarotene (bex) elevated ceramide, a sphingolipid known to induce exosome secretion. The gug+bex combination reduced cellular levels of BCRP to 20% of control cells by inducing its association and secretion with exosomes. Exogenous C6 ceramide also induced secretion of BCRP-associated exosomes, while siRNA-mediated knockdown or GW4869-mediated inhibition of neutral sphingomyelinase 2 (nSMase2), an enzyme generating ceramide, restored cellular BCRP. Immunocytochemistry showed that ceramide elevation and concurrent loss of cellular BCRP was prominent in Aldefluor-labeled breast cancer stem-like cells. These cells no longer excluded the BCRP substrate Hoechst 33342 and showed caspase activation and apoptosis induction. Consistent with reduced BCRP, ABC transporter assays showed that gug+bex increased doxorubicin retention and that the combination of gug+bex with doxorubicin enhanced cell death by more than fivefold. Taken together, our results suggest a novel mechanism by which ceramide induces BCRP secretion and reduces MDR, which may be useful as adjuvant drug treatment for sensitizing breast cancer cells and cancer stem cells to chemotherapy.
|
Authors | Ji Na Kong, Qian He, Guanghu Wang, Somsankar Dasgupta, Michael B Dinkins, Gu Zhu, Austin Kim, Stefka Spassieva, Erhard Bieberich |
Journal | International journal of cancer
(Int J Cancer)
Vol. 137
Issue 7
Pg. 1610-20
(Oct 01 2015)
ISSN: 1097-0215 [Electronic] United States |
PMID | 25833198
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
|
Copyright | © 2015 UICC. |
Chemical References |
- ABCG2 protein, human
- ATP Binding Cassette Transporter, Subfamily G, Member 2
- ATP-Binding Cassette Transporters
- Ceramides
- Neoplasm Proteins
- Pregnenediones
- Tetrahydronaphthalenes
- Doxorubicin
- pregna-4,17-diene-3,16-dione
- Bexarotene
|
Topics |
- ATP Binding Cassette Transporter, Subfamily G, Member 2
- ATP-Binding Cassette Transporters
(metabolism)
- Bexarotene
- Breast Neoplasms
(drug therapy, pathology)
- Cell Death
(drug effects)
- Cell Line, Tumor
- Ceramides
(biosynthesis)
- Down-Regulation
(drug effects)
- Doxorubicin
(pharmacology)
- Drug Resistance, Neoplasm
- Drug Synergism
- Exosomes
(drug effects, metabolism)
- Humans
- Neoplasm Proteins
(metabolism)
- Pregnenediones
(pharmacology)
- Tetrahydronaphthalenes
(pharmacology)
|